Can Direct-to-Consumer Pharma Lower Drug Prices? | Simplefill
Giving consumers direct access to medications can help lower prices significantly. This strategy has come about as a result of the demands of the Trump administration, which is striving to fulfill campaign promises and lower overall drug prices for people throughout the country.
In the past few years, there has been a huge surge of direct-to-consumer (DTC) options for a variety of goods, leading to more affordable options for a variety of items and services. That is now about to become the norm for some medications, too. Learn more about what this means for your bottom line and what your medications will cost.
How Can Direct-to-Consumer Sales Models Make Your Medications More Affordable?
DTC sales can help people throughout the country obtain better rates for the medications they need to address chronic issues like fibromyalgia, obesity, and arthritis.
Getting Rid of the Middleman
When companies engage in DTC strategies, they get rid of middlemen. Insurance companies and pharmacy benefit managers don’t have to be involved in the transaction, and that means they don’t add to the costs. The profits these parties make out of every medication sale are significant, so eliminating them means lower rates for consumers.
Middlemen like pharmacy benefit managers often obtain secret discounts and fees for themselves, leaving regular people with less access to affordable care.
Offering Discounts
Pharmaceutical companies engaging in DTC often offer significant discounts for patients who purchase directly from them. They are also more likely to come up with generic versions of their medications, which are inherently less expensive to begin with.
Providing More Access
Some medications may not be covered by insurance plans, including GLP-1 drugs like Ozempic, which are meant to address diabetes and obesity. Purchasing outside of your insurance plan can be prohibitively expensive. With DTC sales, however, you can afford these medications, too, because the prices will generally be lower.
Aside from making medication more affordable, eliminating middlemen also improves your access to the drugs you need. All too often, pharmacy benefit managers dictate who can and can’t receive certain medications via their health care plans.
They often block patients from receiving certain medications and instead push them toward other medication options, which are typically more expensive.
Patients will not have to deal with pharmacy benefit managers and insurance companies denying their claims or restricting coverage. Prior authorization requirements could also become a thing of the past.
Why Do Pharmaceutical Companies Engage in Direct-to-Consumer Sales?
For one thing, they can receive more for the products they make. Currently, up to half of all drug spending goes toward paying pharmacy benefit managers instead of flowing back to pharmaceutical companies.
By removing these middlemen, companies make larger profits that they can then put toward creating new medications. There are fewer hassles, too, when you cut out many of the moving parts that make the health care system so complex.
As direct-to-consumer drug models expand, patients could see lower prices, faster access, and fewer barriers to care.
Get Affordable Access to Prescription Medications
Simplefill is a full-service prescription assistance company that researches, qualifies, and maintains patients’ enrollment in all sources of assistance available to them.
Apply today by calling 877-386-0206. A caring Simplefill representative will contact you within 24 hours to discuss your application and, if qualified, enroll you in the program.
Frequently Asked Questions
Learn more about direct-to-consumer sales and whether they can help you.
What Are the Benefits of Direct-to-Consumer Drug Medication Sales?
Since middlemen will be removed from the equation, DTC strategies help patients better afford medications. Pharmaceutical companies tend to offer discounts for people who purchase directly from them. You will not have to deal as extensively with insurance companies that could deny your claims or restrict your access to certain medications.
Are There Risks Associated With Direct-to-Consumer Drug Sales?
There are some risks associated with the advertising involved in DTC drug sales. Companies may emphasize certain medications over others to increase their profit margins. This practice could be detrimental if patients don’t know which medications would be best for them. Additionally, pharmaceutical companies could focus on drugs that make them more money instead of investing in new options.
Are All Pharmaceuticals Following Direct-to-Consumer Practices?
Not yet, though more are choosing the DTC model under the pressure that the Trump administration is placing on them to lower costs. This could be an effective way of doing so without damaging their profits.
blog